Form 8-K - Current report:
SEC Accession No. 0001493152-24-047804
Filing Date
2024-11-26
Accepted
2024-11-26 16:10:33
Documents
23
Period of Report
2024-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 73747
2 ex10-1.htm EX-10.1 445772
3 ex10-2.htm EX-10.2 187468
4 ex10-3.htm EX-10.3 198753
5 ex10-4.htm EX-10.4 47075
6 ex10-5.htm EX-10.5 127319
7 ex10-6.htm EX-10.6 97008
8 ex10-7.htm EX-10.6 303530
9 ex10-8.htm EX-10.8 48117
10 ex99-1.htm EX-99.1 16659
  Complete submission text file 0001493152-24-047804.txt   2020151

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE meds-20241122.xsd EX-101.SCH 3009
12 XBRL LABEL FILE meds-20241122_lab.xml EX-101.LAB 34916
13 XBRL PRESENTATION FILE meds-20241122_pre.xml EX-101.PRE 24591
26 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3965
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 241503803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)